IMARC Group, a leading market research company, has recently released a report titled "Artificial Heart-Lung Machine Market Report by Type (Single Roller Pump, Double Roller Pump), Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global artificial heart-lung machine market Trends, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Artificial Heart-Lung Machine Market Highlights:

• Artificial Heart-Lung Machine Market Size: Valued at USD 302.6 Million in 2024.
• Artificial Heart-Lung Machine Market Forecast: The market is expected to reach USD 401.6 Million by 2033, growing at an impressive rate of 3.04% annually.
• Market Growth: The artificial heart-lung machine market is experiencing steady growth driven by the rising prevalence of cardiovascular diseases and increasing number of complex cardiac surgeries worldwide.
• Technology Integration: Advanced modular systems with improved safety features, portability, and rechargeable battery operations are transforming cardiac surgery capabilities.
• Regional Leadership: North America commands the largest market share, fueled by well-established healthcare infrastructure and high adoption of advanced surgical technologies.
• Application Dominance: Cardiac surgeries represent the largest application segment, driven by the growing burden of coronary artery disease and heart valve disorders.
• Key Players: Industry leaders include Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, and Edwards Lifesciences, which dominate the market with cutting-edge cardiopulmonary bypass solutions.
• Market Challenges: The need for highly skilled perfusionists and integration complexities with existing hospital infrastructure present ongoing challenges.

Claim Your Free “Artificial Heart-Lung Machine Market” Insights Sample PDF: https://www.imarcgroup.com/artificial-heart-lung-machine-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends and Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Industry Trends and Drivers:

• Rising Burden of Cardiovascular Diseases:

The global healthcare system is grappling with an unprecedented surge in cardiovascular conditions. Heart disease remains the leading cause of death worldwide, with cardiac surgeries becoming increasingly common across all age groups. The complexity of these procedures has intensified, requiring more sophisticated cardiopulmonary bypass equipment that can handle extended operation times while maintaining optimal patient outcomes. Modern healthcare facilities are now performing thousands of open-heart procedures annually, each requiring reliable artificial heart-lung machines to temporarily take over the critical functions of the heart and lungs. This massive surgical volume is pushing hospitals to upgrade their equipment and invest in next-generation systems that offer better precision and safety margins.

• Technological Breakthroughs Reshaping Cardiac Surgery:

The cardiopulmonary bypass field is witnessing remarkable technological evolution. Manufacturers have introduced modular heart-lung machines that are fundamentally changing how cardiac surgeries are performed. These new systems are notably more portable, allowing for greater flexibility in operating room configurations and even enabling use in emergency situations. The development of rechargeable battery-operated units has eliminated dependency on continuous power supply, adding an extra layer of safety during critical procedures. Engineers have also made significant breakthroughs in preventing blood over-oxygenation, a problem that previously led to complications in some patients. In December 2024, Roivios announced FDA approval of an Investigational Device Exemption for its JuxtaFlow Renal Assist Device, enabling a pivotal trial aimed at improving outcomes for cardiac surgery patients with renal insufficiency. These innovations are making cardiac procedures safer and more accessible to a broader patient population.

• Healthcare Infrastructure Expansion in Emerging Markets:

Governments across developing nations are making substantial commitments to improving healthcare access for their populations. This involves building new cardiac care centers and equipping existing facilities with state-of-the-art surgical equipment. Many countries are implementing national heart health programs that include subsidies for cardiac surgeries and equipment procurement. Public-private partnerships are emerging as a key model for expanding cardiac care infrastructure, with private medical device manufacturers collaborating with government hospitals to provide training and equipment. These initiatives are directly translating into increased demand for artificial heart-lung machines, as newly established cardiac surgery centers require reliable cardiopulmonary bypass systems. The focus isn't just on quantity but on ensuring these facilities have access to modern, efficient equipment that meets international quality standards.

• Growing Complexity of Cardiac Surgical Procedures:

Today's cardiac surgeons are tackling increasingly complex cases that would have been considered impossible just a decade ago. Heart transplants, combined heart-lung transplants, and intricate valve replacement surgeries are becoming more routine. Each of these procedures demands advanced cardiopulmonary bypass systems capable of maintaining stable circulation for extended periods, sometimes lasting several hours. The aging global population means surgeons are also operating on older patients with multiple comorbidities, requiring equipment that can be precisely calibrated to individual patient needs. Single roller pump systems, which currently dominate the market, are being refined to offer better control and monitoring capabilities. Double roller pump systems are gaining traction for complex procedures requiring enhanced perfusion management. The surgical community's growing confidence in handling complicated cases is directly linked to improvements in artificial heart-lung machine technology.

Artificial Heart-Lung Machine Market Report Segmentation:

Breakup by Type:

• Single Roller Pump
• Double Roller Pump

Single roller pump dominates the market, remaining the preferred choice for most cardiac procedures due to its proven reliability and cost-effectiveness.

Breakup by Application:

• Cardiac Surgeries
• Lung Surgeries
• Acute Respiratory Failure Treatment
• Others

Cardiac surgeries lead the market, reflecting the high volume of coronary artery bypass and heart valve procedures performed globally.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Hospitals and clinics account for the largest market share, as they perform the vast majority of cardiac surgeries requiring cardiopulmonary bypass support.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America currently dominates the market, supported by advanced healthcare infrastructure and high cardiac surgery volumes.

Who are the key players operating in the industry?

The report covers the major market players including:

• Medtronic Inc.
• Sorin Group
• MAQUET GmbH & Co KG
• Terumo Corporation
• C.R. Bard Inc.
• Tianjin Welcome Medical Equipment Co., Ltd.
• Edwards Lifesciences
• Jarvik Heart Inc.
• Braile Biomedica
• SynCardia Systems, LLC

Ask Analyst For Request Customization: https://www.imarcgroup.com/request?type=report&id=1537&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302